Lyell Immunopharma Ownership | Who Owns Lyell Immunopharma?
Lyell Immunopharma Ownership Summary
Lyell Immunopharma is owned by 50.11% institutional investors, 14.06% insiders, and 35.83% retail investors. Mwg management is the largest institutional shareholder, holding 7.93% of LYEL shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.27% of its assets in Lyell Immunopharma shares.
LYEL Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Lyell Immunopharma | 50.11% | 14.06% | 35.83% |
| Sector | Healthcare Stocks | 49.73% | 8.84% | 41.43% |
| Industry | Biotech Stocks | 47.04% | 8.74% | 44.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Mwg management | 20.16M | 7.93% | $29.24M |
| Orland properties | 15.09M | 5.94% | $21.89M |
| Blackrock | 13.50M | 5.31% | $19.57M |
| Vanguard group | 13.40M | 5.27% | $19.43M |
| Foresite capital management iv | 8.32M | 3.27% | $12.07M |
| Price t rowe associates inc /md/ | 7.87M | 3.10% | $11.42M |
| Wuxi apptec | 7.68M | 3.02% | $11.14M |
| Orbimed advisors | 6.41M | 2.52% | $9.29M |
| Alphabet | 5.87M | 2.31% | $8.50M |
| Geode capital management | 4.01M | 1.58% | $5.82M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Wuxi apptec | 7.68M | 47.74% | $11.14M |
| Mwg management | 20.16M | 31.93% | $29.24M |
| Orland properties | 15.09M | 16.63% | $21.89M |
| Foresite capital management iv | 8.32M | 8.11% | $12.07M |
| Opaleye management | 1.67M | 0.55% | $2.42M |
| Mic capital management uk llp | 1.74M | 0.55% | $2.52M |
| Alphabet | 5.87M | 0.43% | $8.50M |
| Orbimed advisors | 6.41M | 0.18% | $9.29M |
| Sc china | 3.05M | 0.18% | $5.00M |
| Ikarian capital | 526.07K | 0.13% | $762.80K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Orbimed advisors | 6.41M | 0.18% | 6.21M |
| Price t rowe associates inc /md/ | 7.87M | 0.00% | 1.14M |
| Balyasny asset management | 985.34K | 0.00% | 748.58K |
| Ikarian capital | 526.07K | 0.13% | 526.07K |
| Wellington management group llp | 367.68K | 0.00% | 367.68K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Opaleye management | 1.67M | 0.55% | -1.69M |
| Millennium management | 809.56K | 0.00% | -1.23M |
| Invenomic capital management lp | - | - | -871.52K |
| Massachusetts financial services co /ma/ | - | - | -577.32K |
| Jpmorgan chase | 97.14K | - | -557.48K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Ikarian capital | 526.07K | 0.13% | 526.07K | $762.80K |
| Wellington management group llp | 367.68K | 0.00% | 367.68K | $533.13K |
| Mirae asset global etfs | 312.41K | 0.00% | 312.41K | $452.99K |
| Boothbay fund management | 139.88K | 0.00% | 139.88K | $202.83K |
| Corebridge financial | 86.45K | 0.00% | 86.45K | $125.36K |
Sold Out
| Holder | Change |
|---|---|
| Nelson, van denburg & campbell wealth management group | -34.00 |
| Rothschild investment | -50.00 |
| Riggs asset managment | -150.00 |
| Tyler-stone wealth management | -850.00 |
| Metropolitan life insurance co/ny | -6.62K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2024 | 117 | 0.86% | 128,424,945 | -3.67% | 50 | 1.82% | 51 | 4.08% | 31 | -27.91% |
| Jun 30, 2024 | 116 | -5.69% | 133,324,052 | 0.44% | 52 | 1.91% | 49 | -14.04% | 43 | -2.27% |
| Mar 31, 2024 | 123 | 5.13% | 132,733,881 | 1.13% | 52 | 1.92% | 57 | -1.72% | 44 | 46.67% |
| Dec 31, 2023 | 117 | 12.50% | 131,255,797 | 7.18% | 52 | 2.18% | 58 | -4.92% | 30 | 42.86% |
| Sep 30, 2023 | 104 | 5.05% | 122,457,371 | 0.23% | 48 | 2.04% | 61 | 32.61% | 21 | -38.24% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 5.82M | 2.27% | - |
| T. Rowe Price Health Sciences | 5.40M | 2.11% | -107.67K |
| iShares Russell 2000 ETF | 4.29M | 1.67% | -9.63K |
| Biotech Growth Ord | 2.88M | 1.12% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 2.52M | 0.98% | - |
| Vanguard Small Cap Index | 2.24M | 0.87% | 5.37K |
| Fidelity Small Cap Index | 1.65M | 0.64% | -36.10K |
| iShares Russell 2000 Value ETF | 1.55M | 0.60% | - |
| Vanguard Small Cap Growth Index Inv | 1.25M | 0.49% | -5.54K |
| State St Russell Sm/Mid Cp® Indx NL Cl C | 1.19M | 0.47% | -33.00K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Aug 15, 2023 | Klausner Richard | - | Sell | $132.29K |
| Jun 21, 2021 | FRIEDMAN CATHY | - | Buy | $300.02K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q4 | - | - |
| 2023 Q4 | - | - |
| 2023 Q3 | - | 1 |
| 2023 Q2 | - | - |
| 2023 Q1 | - | - |
LYEL Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools